Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Inhibition of Carbapenem-Resistant Klebsiella Pneumonia and Multi-Drug-Resistant Acinetobacter Baumannii by Nanoemulsion of Satureja Rechingeri Essential Oil Publisher



Moghimi R1 ; Aliahmadi A2 ; Rafati H3 ; Feizabadi MM4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Organic Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, Iran
  2. 2. Department of Biology, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran
  3. 3. Department of Phytochemistry & Chemical Engineering, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran
  4. 4. Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Essential Oil Research Published:2024


Abstract

Multi-drug resistant bacteria (MDR) such as MDR Acinetobacter baumanii and carbapenem-resistant Klebsiella pneumonia have become a global concern in recent decades. In this study, S. rechingeri essential oil was analyzed by GC and GC-MS. After that, different nanoemulsions were produced and the optimum formulation was chosen. In addition, the antibacterial activity of the optimum formulation was evaluated against some strains of A. baumanii and K. pneumoniae. Results showed that carvacrol was the main compound of the essential oil (81.55%) and C3 nanoemulsion with a particle size of 93.14 ± 3.95 nm was the optimum and stable formulation. The antibacterial activity assessment revealed that the C3 nanoemulsion also had better antibacterial activity than essential oil. The herbal formulation had comparable antibacterial activity in comparison with six assessed antibiotics. Overall, nanoencapsulated essential oil of S. rechingeri is a candidate for producing a new generation of natural antibacterial compounds against MDR pathogens. © 2024 Informa UK Limited, trading as Taylor & Francis Group.